Columnist Desiree Lama struggles to effectively manage stress, but given her multiple sclerosis, learning to do so is vital, ...

For more than 60 years, the medical community has been refining the diagnosis of multiple sclerosis. The diagnosis of ...

AlterEgo's neural-interface device is non-invasive and is being tested in people with multiple sclerosis and amyotrophic ...

SHREVEPORT, La. - A cutting-edge clinical trial is now underway in Shreveport, and local patients with Multiple Sclerosis are ...

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of over 30 abstracts from its multiple sclerosis (MS) portfolio. New ...

Understanding how MS can impact your income, insurance, disability benefits, and budgeting allows you to plan ahead with ...

Dr Devon Conway describes how the upcoming conference is expected to provide important new data on the safety and real-world ...

At Year 2, reductions were observed in key biomarkers, including serum glial fibrillary acidic protein (GFAP), immunoglobulin G (IgG) index, and C-X-C motif chemokine ligand 13 (CXCL-13) levels.

Vision loss, balance problems, numbness, and sensitivity to heat could be early signs and symptoms of multiple sclerosis.

A deli assistant with multiple sclerosis has won €4,000 The worker secured the award on foot of a ruling on her complaint ...

A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance ...

Dr Jiwon Oh looks forward to hearing updates on major clinical trials and long-term studies of new and emerging MS treatments at ECTRIMS 2025.